The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Tufts Robert R. since year 2005.
The trader's CIK number is 1410076.
At the time of this reporting, Tufts Robert R. is the Director of Novabay Pharmaceuticals, Inc. .
(stock ticker symbol NBY).
See this page for all insider trading activities at Novabay Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2012-09-27||NBY||Novabay Pharmaceuticals, Inc.||Option Ex||28,500||.56||15,960|
|2011-08-15||NBY||Novabay Pharmaceuticals, Inc.||Buy||5,000||.85||4,240|
|2010-01-04||NBY||Novabay Pharmaceuticals, Inc.||Option Ex||18,158||2.02||36,679|
|2009-08-31||NBY||Novabay Pharmaceuticals, Inc.||Option Ex||20,000||.56||11,200|
|2008-04-22||NBY||Novabay Pharmaceuticals, Inc.||Option Ex||52,000||1.70||88,400|
|2008-03-13||NBY||Novabay Pharmaceuticals, Inc.||Buy||2,500||2.40||6,007|
|2007-10-31||NBY||Novabay Pharmaceuticals, Inc.||Buy||67,500||4.00||270,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tufts Robert R. (Director of Novabay Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.